title: Can bismuth decrease the kidney toxic effect of cis-platinum?
authors.affiliation: Danish Cancer Society, Section of Clinical Research, Aarhus.
authors.forename: S
authors.initials: S
authors.lastname: Sommer
authors.forename: E B
authors.initials: EB
authors.lastname: Thorling
authors.forename: A
authors.initials: A
authors.lastname: Jakobsen
authors.forename: E
authors.initials: E
authors.lastname: Steiness
authors.forename: K
authors.initials: K
authors.lastname: Ostergaard
mesh_terms: D001729:Bismuth / Q000627:therapeutic use*; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012459:Salicylates / Q000627:therapeutic use*
chemical_list: D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; D002945:Cisplatin; D001729:Bismuth